WW International, Inc. has announced its financial results for the third quarter of fiscal 2026, revealing a significant turnaround in its financial performance. The company reported a positive net income of $15.1 million, marking a notable recovery from a net loss of $57.5 million in the same period last year. This improvement is attributed to a strong growth in clinical subscription revenue, which surged by 48% year-over-year, contributing to a total revenue of $153 million for the quarter.
Stephen Bye, the new President and Chief Executive Officer of WW International, emphasized the importance of understanding member needs and enhancing the company's offerings. "Our strength lies in the commitment of our team and our ability to bring together science-backed behavioral programs, clinical care, and the human connection that has defined this brand for more than 60 years," Bye stated. The company aims to continue strengthening its member experience and improving its products.
WW International, Inc., formerly known as Weight Watchers International, Inc., operates in the personal services sector (SIC: 7200). The company trades on the Nasdaq under the ticker symbol WW. The latest filing, dated November 5, 2026, includes a press release and a shareholder letter detailing the financial results for the quarter ending September 30, 2026. The filing is accessible via the SEC's website with accession number 0001193125-26-448523.
According to the filing, the company reported a total of 2.3 million subscribers at the end of the quarter, with notable growth in its higher-value product offerings. The Core+ subscriber count reached 546,000, reflecting a 16% increase year-over-year, while clinical subscribers totaled 174,000, up 40% from the previous year. This growth in subscriptions is indicative of changing consumer preferences towards personalized health and wellness solutions.
WW International's Chief Financial Officer, Felicia DellaFortuna, highlighted the company's focus on maintaining disciplined spending while driving growth in its premium offerings. The company's Adjusted EBITDA for the quarter was reported at $51.7 million, representing a margin of 33.8%. This reflects the effectiveness of their strategies to balance investment with revenue growth.
Looking ahead, WW International has narrowed its full-year revenue guidance for fiscal 2026 to a range of $625 million to $630 million. The company also adjusted its Adjusted EBITDA guidance to between $110 million and $115 million, indicating a positive outlook for the remainder of the fiscal year.
The results from WW International may have implications for competitors in the personal services industry, as the company continues to innovate and adapt to consumer needs. The focus on clinical subscription growth and member engagement is likely to influence market dynamics, as other companies may need to enhance their offerings to keep pace.
As the company moves forward, it plans to hold a conference call to discuss these results in detail and outline its strategy for future growth. The ongoing commitment to improving member experiences and expanding product offerings will be crucial as WW International navigates the competitive landscape of the personal services sector.
Read Next
Ronald N. Tutor sells 150,000 shares of Tutor Perini Corp.
Generation Income Properties reports Q3 2026 results
Greenlane Holdings reports Q3 2026 results amid challenges
Permianville Royalty Trust Reports Q3 Financial Results
Cue Biopharma Reports Q3 Results with Financial Insights
Atlantica Inc Reports Q3 Results, Highlights Financial Updates










